Helping Latinas access breast cancer care
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
This study is trying to help Latina women at higher risk for breast cancer by giving them personalized support and education over the phone about breast cancer care, diet, and exercise.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 30 Years and up |
| Sex | Female |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05483283 on ClinicalTrials.gov |
What this trial studies
This study aims to empower Latina women at elevated genetic and social risk for breast cancer by providing them with personalized education and support. Participants will engage in three individual phone-based sessions over three weeks, focusing on breast cancer care, diet, and physical activity. The sessions will include testimonials and action plans to address disparities in breast cancer care uptake. Participants will also receive multimedia materials to reinforce the information shared during the sessions.
Who should consider this trial
Good fit: Ideal candidates are Latina women aged 30 and older with a genetic risk factor for breast cancer and a social determinant of health risk.
Not a fit: Patients who do not identify as Latina or who have already received genetic counseling or testing may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve breast cancer care access and outcomes for vulnerable Latina women.
How similar studies have performed: Other studies have shown success in using empowerment and education to improve health outcomes in similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Aim 1 1. female biological sex 2. identification as Latina 3. one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer) 4. one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges) 5. 30+ years old, based on American Cancer Society (ACS) screening guidelines for high risk populations 6. No receipt of cancer genetic counseling AND no receipt of genetic testing Aim 2 1. female biological sex 2. referral from Latina Aim 1 participants 3. eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual 4. screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older) 5. self-report not attending Session #3 (as this will not be recorded by the staff) Aim 3 1. participant from Aim 1 or 2. participant from Aim 2 Exclusion Criteria: Aim 1 and Aim 2 Not meeting at least one of the inclusion criteria Aim 3 1. Not a participant from Aim 1 or 2. Not a participant from Aim 2
Where this trial is running
Chicago, Illinois
- University of Illinois — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Yamile Molina, PhD
- Email: ymolin2@uic.edu
- Phone: 312-355-2679
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.